Your browser doesn't support javascript.
loading
Further Evidence that Inhibition of Neuronal Voltage-Gated Calcium Channels Contributes to the Hypnotic Effect of Neurosteroid Analogue, 3ß-OH.
Timic Stamenic, Tamara; Manzella, Francesca M; Maksimovic, Stefan; Krishnan, Kathiresan; Covey, Douglas F; Jevtovic-Todorovic, Vesna; Todorovic, Slobodan M.
Afiliação
  • Timic Stamenic T; Department of Anesthesiology, University of Colorado, Anschutz Medical Campus, Aurora, United States.
  • Manzella FM; Department of Anesthesiology, University of Colorado, Anschutz Medical Campus, Aurora, United States.
  • Maksimovic S; Neuroscience Graduate Program, University of Colorado, Anschutz Medical Campus, Aurora, United States.
  • Krishnan K; Department of Anesthesiology, University of Colorado, Anschutz Medical Campus, Aurora, United States.
  • Covey DF; Department of Developmental Biology, Washington University School of Medicine, Saint Louis, MO, United States.
  • Jevtovic-Todorovic V; Department of Developmental Biology, Washington University School of Medicine, Saint Louis, MO, United States.
  • Todorovic SM; Taylor Family Institute for Innovative Psychiatric Research, Washington University School of Medicine, Saint Louis, MO, United States.
Front Pharmacol ; 13: 850658, 2022.
Article em En | MEDLINE | ID: mdl-35677453
ABSTRACT
We recently reported that a neurosteroid analogue with T-channel-blocking properties (3ß,5ß,17ß)-3-hydroxyandrostane-17-carbonitrile (3ß-OH), induced hypnosis in rat pups without triggering neuronal apoptosis. Furthermore, we found that the inhibition of the CaV3.1 isoform of T-channels contributes to the hypnotic properties of 3ß-OH in adult mice. However, the specific mechanisms underlying the role of other subtypes of voltage-gated calcium channels in thalamocortical excitability and oscillations in vivo during 3ß-OH-induced hypnosis are largely unknown. Here, we used patch-clamp recordings from acute brain slices, in vivo electroencephalogram (EEG) recordings, and mouse genetics with wild-type (WT) and CaV2.3 knock-out (KO) mice to further investigate the molecular mechanisms of neurosteroid-induced hypnosis. Our voltage-clamp recordings showed that 3ß-OH inhibited recombinant CaV2.3 currents. In subsequent current-clamp recordings in thalamic slices ex vivo, we found that selective CaV2.3 channel blocker (SNX-482) inhibited stimulated tonic firing and increased the threshold for rebound burst firing in WT animals. Additionally, in thalamic slices we found that 3ß-OH inhibited spike-firing more profoundly in WT than in mutant mice. Furthermore, 3ß-OH reduced bursting frequencies in WT but not mutant animals. In ensuing in vivo experiments, we found that intra-peritoneal injections of 3ß-OH were less effective in inducing LORR in the mutant mice than in the WT mice, with expected sex differences. Furthermore, the reduction in total α, ß, and low γ EEG power was more profound in WT than in CaV2.3 KO females over time, while at 60 min after injections of 3ß-OH, the increase in relative ß power was higher in mutant females. In addition, 3ß-OH depressed EEG power more strongly in the male WT than in the mutant mice and significantly increased the relative δ power oscillations in WT male mice in comparison to the mutant male animals. Our results demonstrate for the first time the importance of the CaV2.3 subtype of voltage-gated calcium channels in thalamocortical excitability and the oscillations that underlie neurosteroid-induced hypnosis.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article